2025-10-29T15:33:39-05:00 2024-12-31 582676261 Rogers & Company PLLC 8300 Boone Boulevard Suite 600 Vienna VA 22182 990 2024-01-01 320020119 ASTS Foundation ASTS 7034147870 1401 South Clark St Ste 1120 Arlington VA 222024165 Maggie Kebler-Bullock Executive Director/CEO 7034147870 2025-10-29 1 1 Lori A Collingsworth P00639819 7038930300 2025-10-27 2024 2025-03-06 01:10:19Z Maggie Kebler-Bullock 1401 South Clark St Ste 1120 Arlington VA 222024165 8639051 0 X https://www.asts.org/asts-foundation X 2002 VA Promote philanthropy in the field of transplant surgery. 12 12 0 50 0 0 691413 841244 0 0 438625 992386 0 0 1130038 1833630 600750 1041250 0 0 67641 65102 0 0 101339 67641 256173 736032 1362525 394006 471105 22913743 25148137 712660 1110182 22201083 24037955 The mission of the ASTS Foundation is to promote philanthropy in the field of transplant surgery. Funds generated will be used to provide support for ASTS sponsored initiatives such as education, fellowships and other training, and research. 0 0 1131127 1041250 The Foundation, through strategic partnerships, provides funding for research grants designed to advance the field of organ transplantations and recognizes the scientific accomplishments of its members. Research grants and recognition awards are available to the Society's members and their trainees throughout the United States and Canada. 1131127 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 X 23 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 AL AK AZ CA CO CT DE FL GA IL KS KY MA ME MD MN MI MO NJ NM NY NC ND OH OK OR PA RI SC TN TX UT VA WA WV WI X Maggie Kebler-Bullock 7034147870 1401 South Clark St Ste 1120 Arlington VA 222024165 Thomas G Peters MD Chair 0.50 0.00 X X 0 0 0 Christopher L Marsh MD FACS Vice Chair 1.00 0.00 X X 0 0 0 Debra Sundan MD Secretary 1.00 1.00 X X 0 0 0 Julie Heimbach MD Treasurer 1.00 1.00 X X 0 0 0 Elizabeth A Pomfret MD PhD Director 5.00 3.00 X 0 0 0 Ginny L Bumgardner MD PhD Director 5.00 5.00 X 0 0 0 Majella B Doyle MD MBA Director 0.50 0.50 X 0 0 0 James D Eason MD PhD Director 0.50 0.00 X 0 0 0 David C Mulligan MD Director 0.50 0.00 X 0 0 0 Matthew H Levine MD PhD Director 0.50 0.50 X 0 0 0 James F Markmann MD PhD Director 0.50 5.00 X 0 0 0 Mark R Ghobrial MD PhD Director 0.50 0.00 X 0 0 0 Robert Montgomery MD PhD Director 0.50 0.50 X 0 0 0 Jayme E Locke MD MPH Director 0.50 0.50 X 0 0 0 Dorry L Segev MD PhD Director 0.50 0.00 X 0 0 0 Maggie Kebler-Bullock Executive Director/ CEO 2.00 38.00 X 0 236504 53327 Diane Mossholder Chief Operating Officer 2.00 38.00 X 0 158869 40652 0 395373 93979 0 0 1 0 0 841244 841244 600774 600774 7197033 6805421 391612 391612 391612 1833630 0 0 992386 1041250 1041250 46293 21901 10941 13451 2986 1413 603 970 10886 5149 2199 3538 4937 2336 997 1604 418 418 5854 5854 87555 87555 24416 8950 15466 30876 10922 738 19216 18355 10467 4509 3379 4858 4858 31354 24307 7047 37386 4432 969 31985 763 763 1649 1649 State registrations 11730 11730 Taxes and licenses 959 959 1362525 1131127 130059 101339 387436 246792 259084 391325 47066 225000 17015 0 22116659 24151470 86483 133550 22913743 25148137 470160 4264 192500 442500 50000 0 0 663418 712660 1110182 X 20656982 22391302 1544101 1646653 22201083 24037955 22913743 25148137 X 471105 1362219 3548 X X 0 1 X 1 1 1 X X 1 American Society of Transplant Surgeons 133048373 7 1 0 1131127 1 0 1131127 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 Due to the Society 663418 663418 X Part X, Line 2: Management has evaluated ASTS' tax positions and concluded that ASTS' consolidated financial statements do not include any uncertain tax positions. 1 Ronald and JoAnn Busuttil Surgeon Scientist Scholarship 1 100000 0 Fellowship in Transplantation 3 127500 0 Collaborative Scientist Grant 2 100000 0 Socio Economic and Racial Disperity Grant 4 100000 0 Faculty Development Grant 2 100000 0 Faculty Perfusion Grant 2 400000 0 Resident Scientist 1 40000 0 Honoraria 31 61750 0 Advanced Transplant Provider Grant 3 12000 0 Part I, Line 2: Grants are awarded based on a competitive review by the Foundation's leadership, grants review committee members and members-at-large. A budget is required for each grant application and any variance from the submitted budget requires approval of the grants review committee. For grants $10,000 and greater, checks are issued to the institution, often in two installments. Prior to dispersing the second installment, a progress report is due to the Foundation. Any concerns are addressed prior to issuing the remaining funds. Grants of less than $10,000 are paid as a single payment. 0 0 0 0 0 0 0 0 0 Maggie Kebler-Bullock Executive Director/ CEO 0 227104 0 9400 0 0 0 12681 0 40646 0 289831 0 0 Diane Mossholder Chief Operating Officer 0 158869 0 0 0 0 0 7979 0 32673 0 199521 0 0 Part I, Line 3 The Foundation does not directly hire or compensate employees. All employees are employees of the American Society of Transplant Surgeons, a related organization. The cost of the Society's officer and highly compensated employees are allocated under the terms of a cost sharing agreement. The Society's methods for establishing compensation of the top management officials include: Compensation committee Form 990 of other organizations Compensation survey or study Approval by the board or compensation committee Form 990, Part V, Line 2a: The Foundation does not directly hire or compensate employees. All employees are employees of the American Society of Transplant Surgeons, a related organization. The cost of the Society's officer and highly compensated employees are allocated under the terms of a cost sharing agreement. As such, the Foundation is reporting zero employees on the Form W-3 for the calendar year ending with or within the year covered by this return. Form 990, Part VI, Section A, line 7a The membership of American Society of Transplant Surgeons, a related organization, elect the governing body which serves both the Society and the Foundation. Form 990, Part VI, Section B, line 11b The Federal Form 990 is prepared by an independent accountant and upon submission of the draft, is reviewed by the Secretary/Treasurer and Executive Director. The form 990 is presented to the Board of Directors for review and discussion prior to finalizing with the Internal Revenue Service. Formal approval is recorded in the minutes. Form 990, Part VI, Section B, line 12c To ensure accurate, up to date information, each board member reviews their disclosure statement during face-to-face meetings and updates as necessary between meetings. Each board member clearly describes their interest in each such issue, subject, person or entity on this form and return to the Foundation's Executive Director. The information on this form is reviewed by the President and Executive Director, and shared with the Board of Directors if relevant to the discussion at hand. The board member may voluntarily recuse themself from discussion and/or voting on the basis of a conflict of interest. In addition, the Board of Directors may require that the Foundation's board member: (a) refrain from voting on the issue, (b) not participate in either the discussion or the vote on the issue, (c) leave the room during discussion and voting on the issue, or (d) explain their interest in the matter fully so the Board of Directors may weigh the board member's further participation. Form 990, Part VI, Section C, line 19 Governing documents and the Conflict of Interest Policy are available on the public portion of the website. Financial statements are provided upon request. Form 990, Part XI, line 9: Return of 2022 unused grant funds 3,548. Form 990, Part XII, Line 2c: The Council/Board and the Society's Finance Committee are responsible for the oversight of the consolidated audit, including the selection of the independent accountant. The process is consistent with previous years. American Society of Transplant Surgeons 1401 South Clark St Ste 1120 Arlington VA 222024165 133048373 To advance the art and science of transplant surgery OR 501(c)(3) Line 7 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0